Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases |
Kim, Hye-Jin
(Department of Internal Medicine, Soonchunhyang University College of Medicine)
Koo, So-My (Department of Internal Medicine, Soonchunhyang University College of Medicine) Ham, Nam-Suk (Department of Internal Medicine, Soonchunhyang University College of Medicine) Kim, Ki-Up (Department of Internal Medicine, Soonchunhyang University College of Medicine) Uh, Soo-Taek (Department of Internal Medicine, Soonchunhyang University College of Medicine) Kim, Yang-Ki (Department of Internal Medicine, Soonchunhyang University College of Medicine) |
1 | Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788-830. DOI ScienceOn |
2 | Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:e419S-94S. |
3 | Piazza G, Goldhaber SZ. Fibrinolysis for acute pulmonary embolism. Vasc Med 2010;15:419-28. DOI ScienceOn |
4 | EINSTEIN-PE Investigators, Buller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012;366:1287-97. DOI ScienceOn |
5 | EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363:2499-510. DOI ScienceOn |
![]() |